Xiaojie Wu

1.1k total citations
71 papers, 818 citations indexed

About

Xiaojie Wu is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Xiaojie Wu has authored 71 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 33 papers in Epidemiology and 23 papers in Molecular Medicine. Recurrent topics in Xiaojie Wu's work include Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (23 papers) and Antibiotic Resistance in Bacteria (23 papers). Xiaojie Wu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (23 papers) and Antibiotic Resistance in Bacteria (23 papers). Xiaojie Wu collaborates with scholars based in China, United States and Australia. Xiaojie Wu's co-authors include Jicheng Yu, Guoying Cao, Jing Zhang, Beining Guo, Yuancheng Chen, Jufang Wu, Yingyuan Zhang, Yaxin Fan, Miao Zhao and Jing Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiaojie Wu

68 papers receiving 807 citations

Peers

Countries citing papers authored by Xiaojie Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaojie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Wu more than expected).

Fields of papers citing papers by Xiaojie Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Wu. The network helps show where Xiaojie Wu may publish in the future.

Co-authorship network of co-authors of Xiaojie Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Wu. A scholar is included among the top collaborators of Xiaojie Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Wu. Xiaojie Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects 2024 ·International Journal of Antimicrobial Agents ·Xiaolan Huang, Xiaofen Liu, Yaxin Fan, (unknown), Beining Guo, Jingjing Wang, Jicheng Yu, Qiong Wei, Xiaojie Wu, Haihui Huang, Jing Zhang	1
2	Potential and Observed Supply–Demand Characteristics of Medical Services: A Case Study of Nighttime Visits in Shenzhen 2024 ·ISPRS International Journal of Geo-Information ·Xiaojie Wu, Zhengdong Huang, (unknown)	0
3	Additions/removals of seeds before fermentation alters Cabernet Sauvignon wine color via modulating anthocyanins and derivatives 2024 ·LWT ·Zhaoxiang Wang, Lin Zhang, (unknown), Xiaojie Wu, Chunlong Yuan	1
4	Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia 2024 ·Frontiers in Pharmacology ·(unknown), (unknown), Yi Li, Xu Zhu, Jicheng Yu, Yingying Hu, (unknown), Qiong Wei, Xiaojie Wu, Jingjing Wang, Guoying Cao, (unknown), Yang Wang, Jing Zhang	0
5	In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales 2024 ·Frontiers in Pharmacology ·Zhiwei Huang, (unknown), Yi Li, Jiali Hu, Beining Guo, Xinyi Yang, Yi Jin, (unknown), Xinmei Wang, Gao Cong, Jing Zhang, Xiaojie Wu	3
6	LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects 2023 ·Frontiers in Pharmacology ·(unknown), Jingjing Wang, Jinjie He, Yingying Hu, (unknown), (unknown), (unknown), Jicheng Yu, Xiaojie Wu, (unknown), Wei Fang, (unknown), Jing Zhang	2
7	A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects 2023 ·International Journal of Antimicrobial Agents ·(unknown), Peipei Wang, Xin Li, Qiong Wei, Jicheng Yu, Xiaojie Wu, Ying Huang, (unknown), (unknown), Shaoqing Zeng, Hailan Wu, Shuhai Wang, Jing Zhang	2
8	Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study 2023 ·Expert Opinion on Investigational Drugs ·Jinjie He, (unknown), (unknown), (unknown), (unknown), Qingyang Ma, (unknown), Jicheng Yu, Xiaojie Wu, Jufang Wu, Yuancheng Chen, Guoying Cao, Jing Zhang	2
9	Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects 2023 ·Antibiotics ·Yingying Hu, Qiong Wei, (unknown), Xinyi Yang, Jicheng Yu, Jingjing Wang, (unknown), Guoying Cao, Xiaojie Wu, Jing Zhang	3
10	[Clinical analysis of amphotericin B cholesteryl sulfate complex for injection in the treatment of invasive fungal disease for patients with hematological malignancies in 30 cases]. 2022 ·PubMed ·(unknown), (unknown), Xiaojie Wu, Maohua Miao, (unknown), (unknown), Huizhong Qiu, (unknown), (unknown), (unknown), (unknown), Shengli Xue, Xinxing Ma, Depei Wu	1
11	Comparative assessment of pharmacokinetic parameters between HS016, an adalimumab biosimilar, and adalimumab (Humira®) in healthy subjects and ankylosing spondylitis patients: Population pharmacokinetic modeling 2022 ·Advances in Clinical and Experimental Medicine ·Xiaofeng Zeng, (unknown), Xiaojie Wu, Yuancheng Chen, (unknown), (unknown), (unknown), (unknown), Guoying Cao	3
12	Detection of the Disorders of Glycerophospholipids and Amino Acids Metabolism in Lung Tissue From Male COPD Patients 2022 ·Frontiers in Molecular Biosciences ·(unknown), Xiaojie Wu, (unknown), Ting Wang, Yuan Zhan, Jinkun Chen, Zhilin Zeng, Yongman Lv, Jianping Zhao, Jungang Xie	8
13	Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients 2020 ·Clinical Therapeutics ·Li Li, Hailan Wu, Yuancheng Chen, Hong Yuan, Junzhen Wu, Xiaojie Wu, Yingyuan Zhang, Guoying Cao, Beining Guo, Jufang Wu, Ming Zhao, (unknown)	19
14	Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma 2018 ·Current Problems in Cancer ·Xiaojie Wu, (unknown), (unknown), Luying Liu, Qiang Fu, (unknown), (unknown), (unknown), Hongrui Liu, Yong Gao, (unknown)	28
15	Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography–tandem mass spectrometry 2018 ·Journal of Chromatography B ·(unknown), Beining Guo, Jing Zhang, Yi Li, Xiaojie Wu, Yaxin Fan, Yuancheng Chen, Guoying Cao, Jicheng Yu	10
16	Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis 2017 ·Clinical Therapeutics ·Beining Guo, (unknown), Xiaojie Wu, Jicheng Yu, Guoying Cao, Yi Li, Yaxin Fan, Yuancheng Chen, (unknown), Yingyuan Zhang, Jing Zhang	3
17	Rapid and Simultaneous Quantitation of Amoxicillin and Clavulanic Acid in Human Plasma and Urine by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study 2016 ·Analytical Sciences ·Yaxin Fan, Xiaojie Wu, Miao Zhao, Beining Guo, Guoying Cao, Jicheng Yu, Yuancheng Chen, Jing Zhang	11
18	LC-MS/MS determination of colistin in Mueller–Hinton broth for in vitro pharmacodynamic studies 2014 ·The Journal of Antibiotics ·Miao Zhao, (unknown), Beining Guo, Xiaojie Wu, Jian Li, Jing Zhang	14
19	In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation 2014 ·Journal of Pharmacokinetics and Pharmacodynamics ·Yuancheng Chen, Liang Wang, Jiali Hu, (unknown), Xiaojie Wu, Xiaofang Liu, Jing Zhang, (unknown)	1
20	Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China 2009 ·Journal of Infection and Chemotherapy ·Jing Zhang, (unknown), Xiaojie Wu, Guoying Cao, (unknown), Yingyuan Zhang, Yanbin Liu, (unknown), Jian‐An Huang, (unknown), Shenghua Sun, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact